Team 5 publications

Team 5 publications (2014-)

  1. Rosenbaum D, Gallo A, Lethielleux G, Bruckert E, Levy BI, Tanguy ML, Dulon J, Dahmoune N, Salem JE, Bittar R, Leban M, Girerd X, Touraine P, Bachelot A; CARDIOHCS study group. Early central blood pressure elevation in adult patients with 21-hydroxylase deficiency. J Hypertens. 2019;37(1):175-181.
  2. Guerin M, Silvain J, Gall J, Darabi M, Berthet M, Frisdal E, Hauguel-Moreau M, Zeitouni M, Kerneis M, Lattuca B, Brugier D, Collet JP, Lesnik P, Montalescot G. Association of Serum Cholesterol Efflux Capacity With Mortality in Patients With ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol. 2018;72(25):3259-3269.
  3. Franceschini N, Giambartolomei C, de Vries PS, et al. GWAS and colocalization analyses implicate carotid intima-media thickness and carotid plaque loci in cardiovascular outcomes. Nat Commun. 2018;9(1):5141.
  4. El Khoury P, Couvert P, Elbitar S, Ghaleb Y, Abou-Khalil Y, Azar Y, Ayoub C, Superville A, Guérin M, Rabès JP, Varret M, Boileau C, Jambart S, Giral P, Carrié A, Le Goff W, Abifadel M. Identification of the first Tangier disease patient in Lebanon carrying a new pathogenic variant in ABCA1. J Clin Lipidol. 2018;12(6):1374-1382.
  5. Veglia F, Baldassarre D, de Faire U, Kurl S, Smit AJ, Rauramaa R, Giral P, Amato M, Di Minno A, Ravani A, Frigerio B, Castelnuovo S, Sansaro D, Coggi D, Bonomi A, Tedesco CC, Mannarino E, Humphries SE, Hamsten A, Tremoli E; IMPROVE study group. A priori-defined Mediterranean-like dietary pattern predicts cardiovascular events better in north Europe than in Mediterranean countries. Int J Cardiol. 2018. pii: S0167-5273(18)35681-X.
  6. Moulin P, Dufour R, Averna M, Arca M, Cefalù AB, Noto D, D’Erasmo L, Di Costanzo A, Marçais C, Walther LAA, Banach M, Borén J, Cramb R, Gouni-Berthold I, Hughes E, Johnson C, Pintó X, Reiner Ž, van Lennep JR, Soran H, Stefanutti C, Stroes E, Bruckert E. Characterisation of patients with familial chylomicronaemia syndrome (FCS) and multifactorial chylomicronaemia syndrome (MCS): Establishment of an FCS clinical diagnostic score. Data Brief. 2018;21:1334-1336.
  7. Fischer Q, Georges JL, Le Feuvre C, Sharma A, Hammoudi N, Berman E, Cohen S, Jolivet I, Silvain J, Helft G. Optimal long-term antithrombotic treatment of patients with stable coronary artery disease and atrial fibrillation: “OLTAT registry”. Int J Cardiol. 2018;264:64-69.
  8. Helft G, Le Feuvre C, Zaman A. Rivaroxaban in Stable Cardiovascular Disease.N Engl J Med. 2018 Jan 25;378(4):397. doi: 10.1056/NEJMc1714934. No abstract available.Zeitouni M, Silvain J, Guedeney P, Kerneis M, Yan Y, Overtchouk P, Barthelemy O, Hauguel-Moreau M, Choussat R, Helft G, Le Feuvre C, Collet JP, Montalescot G; ACTION Study Group. Periprocedural myocardial infarction and injury in elective coronary stenting. Eur Heart J. 2018;39(13):1100-1109.
  9. Dietenbeck T, Craiem D, Rosenbaum D, Giron A, De Cesare A, Bouaou K, Girerd X, Cluzel P, Redheuil A, Kachenoura N. 3D aortic morphology and stiffness in MRI using semi-automated cylindrical active surface provides optimized description of the vascular effects of aging and hypertension. Comput Biol Med. 2018;103:101-108.
  10. Lefort M, Neufcourt L, Pannier B, Vaïsse B, Bayat S, Grimaud O, Girerd X. Sex differences in adherence to antihypertensive treatment in patients aged above 55: The French League Against Hypertension Survey (FLAHS). J Clin Hypertens (Greenwich). 2018;20(10):1496-1503.
  11. Muñoz-Hernandez L, Ortiz-Bautista RJ, Brito-Córdova G, Lozano-Arvizu F, Saucedo S, Pérez-Méndez O, Zentella-Dehesa A, Dauteuille C, Lhomme M, Lesnik P, Chapman MJ, Kontush A, Aguilar Salinas CA. Cholesterol efflux capacity of large, small and total HDL particles is unaltered by atorvastatin in patients with type 2 diabetes. Atherosclerosis. 2018;277:72-79.
  12. Bouhanick B, Amar J, Amar L, Gosse P, Girerd X, Reznik Y, Mounier-Vehier C, Baguet JP, Boutouyrie P, Lepage B, Lantelme P, Chamontin B; investigators of the ASAPAS study. Arterial stiffness evaluated by pulse wave velocity is not predictive of the improvement in hypertension after adrenal surgery for primary aldosteronism: A multicentre study from the French European Society of Hypertension Excellence Centres. Arch Cardiovasc Dis. 2018;111(10):564-572.
  13. Pais R, Redheuil A, Cluzel P, Ratziu V, Giral P. Relationship between fatty liver, specific and multiple-site atherosclerosis and 10-year Framingham Score. Hepatology. 2018 Aug 19.
  14. Cohen-Aubart F, Guerin M, Poupel L, Cluzel P, Saint-Charles F, Charlotte F, Arsafi Y, Emile JF, Frisdal E, Le Goff C, Donadieu J, Amoura Z, Lesnik P, Haroche J, Le Goff W. Hypoalphalipoproteinemia and BRAFV600E Mutation Are Major Predictors of Aortic Infiltration in the Erdheim-Chester Disease. Arterioscler Thromb Vasc Biol. 2018;38(8):1913-1925.
  15. Giral P. Comparison of Five Major Guidelines for Statin Use in Primary Prevention. Ann Intern Med. 2018;169(1):67.
  16. Dufay A, Gallo A, Hanon O, Vaïsse B, Girerd X. The repercussion of stopping reimbursement of olmésartan on antihypertensive drugs prescription and blood pressure control of treated hypertensive patients in France. Ann Cardiol Angeiol (Paris). 2018;67(3):149-153.
  17. Girerd X, Hanon O, Vaïsse B. [Use of the EvalObs® adherence scale in an unselected French population of treated subjects with antihypertensive, hypolipemiants or oral antidiabetics medications: The FLAHS 2017 adherence survey]. Ann Cardiol Angeiol (Paris). 2018;67(3):186-190.
  18. Alili R, Nivet-Antoine V, Saldmann A, Golmard JL, Cottart CH, Laguillier C, Giral P, Beaudeux JL, Bouillot JL, Poitou C, Clément K, Hébert-Schuster M. Human catalase gene promoter haplotype and cardiometabolic improvement after bariatric surgery. Gene. 2018;656:17-21.
  19. Viaud M, Ivanov S, Vujic N, Duta-Mare M, Aira LE, Barouillet T, Garcia E, Orange F, Dugail I, Hainault I, Stehlik C, Marchetti S, Boyer L, Guinamard R, Foufelle F, Bochem A, Hovingh KG, Thorp EB, Gautier EL, Kratky D, Dasilva-Jardine P, Yvan-Charvet L. Lysosomal Cholesterol Hydrolysis Couples Efferocytosis to Anti-Inflammatory Oxysterol Production. Circ Res. 2018;122(10):1369-1384.
  20. Chapman MJ, Orsoni A, Robillard P, Therond P, Giral P. Duality of statin action on lipoprotein subpopulations in the mixed dyslipidemia of metabolic syndrome: Quantity vs quality over time and implication of CETP. J Clin Lipidol. 2018;12(3):784-800.e4.
  21. Touch S, Assmann KE, Aron-Wisnewsky J, Marquet F, Rouault C, Fradet M, Mosbah H, Consortium M, Isnard R, Helft G, Lehuen A, Poitou C, Clément K, André S; MetaCardis Consortium. Mucosal-associated invariant T (MAIT) cells are depleted and prone to apoptosis in cardiometabolic disorders. FASEB J. 2018:fj201800052RR.
  22. Hansel B, Roussel R, Giral P. Associations of fats and carbohydrates with cardiovascular disease and mortality-PURE and simple? Lancet. 2018;391(10131):1680.
  23. Cirera S, Clop A, Jacobsen MJ, Guerin M, Lesnik P, Jørgensen CB, Fredholm M, Karlskov-Mortensen P. A targeted genotyping approach enhances identification of variants in taste receptor and appetite/reward genes of potential functional importance for obesity-related porcine traits. Anim Genet. 2018;49(2):110-118.
  24. Tedesco CC, Veglia F, de Faire U, Kurl S, Smit AJ, Rauramaa R, Giral P, Amato M, Bonomi A, Ravani A, Frigerio B, Castelnuovo S, Sansaro D, Mannarino E, Humphries SE, Hamsten A, Tremoli E, Baldassarre D; IMPROVE study group. Association of lifelong occupation and educational level with subclinical atherosclerosis in different European regions. Results from the IMPROVE study. Atherosclerosis. 2018;269:129-137.
  25. Kamleh MA, McLeod O, Checa A, Baldassarre D, Veglia F, Gertow K, Humphries SE, Rauramaa R, de Faire U, Smit AJ, Giral P, Kurl S, Mannarino E, Tremoli E, Silveira A, Örvik J, Hamsten A, Wheelock CE. Increased Levels of Circulating Fatty Acids Are Associated with Protective Effects against Future Cardiovascular Events in Nondiabetics. J Proteome Res. 2018;17(2):870-878.
  26. Coste J, Billionnet C, Rudnichi A, Pouchot J, Dray-Spira R, Giral P, Zureik M. Statins for primary prevention and rhabdomyolysis: A nationwide cohort study in France. Eur J Prev Cardiol. 2018:2047487318776831.
  27. Perségol L, Darabi M, Dauteuille C, Lhomme M, Chantepie S, Rye KA, Therond P, Chapman MJ, Salvayre R, Nègre-Salvayre A, Lesnik P, Monier S, Kontush A. Small dense HDLs display potent vasorelaxing activity, reflecting their elevated content of sphingosine-1-phosphate. J Lipid Res. 2018;59(1):25-34.
  28. Béliard S, Le Goff W, Saint-Charles F, Poupel L, Deswaerte V, Bouchareychas L, Huby T, Lesnik P. Modulation of Gr1low monocyte subset impacts insulin sensitivity and weight gain upon high-fat diet in female mice. Int J Obes (Lond). 2017;41(12):1805-1814..
  29. Mahdessian H, Perisic Matic L, Lengquist M, Gertow K, Sennblad B, Baldassarre D, Veglia F, Humphries SE, Rauramaa R, de Faire U, Smit AJ, Giral P, Kurl S, Mannarino E, Tremoli E, Hamsten A, Eriksson P, Hedin U, Mälarstig A; IMPROVE study group. Integrative studies implicate matrix metalloproteinase-12 as a culprit gene for large-artery atherosclerotic stroke. J Intern Med. 2017;282(5):429-444.
  30. Strawbridge RJ, Silveira A, Hoed MD, et al; IMPROVE study group. Identification of a novel proinsulin-associated SNP and demonstration that proinsulin is unlikely to be a causal factor in subclinical vascular remodelling using Mendelian randomisation. Atherosclerosis. 2017;266:196-204.
  31. Hansel B, Giral P, Gambotti L, Lafourcade A, Peres G, Filipecki C, Kadouch D, Hartemann A, Oppert JM, Bruckert E, Marre M, Bruneel A, Duchene E, Roussel R. A Fully Automated Web-Based Program Improves Lifestyle Habits and HbA1c in Patients With Type 2 Diabetes and Abdominal Obesity: Randomized Trial of Patient E-Coaching Nutritional Support (The ANODE Study). J Med Internet Res. 2017;19(11):e360. doi: 10.2196/jmir.7947.
  32. Courand PY, Pereira H, Del Giudice C, Gosse P, Monge M, Bobrie G, Delsart P, Mounier-Vehier C, Lantelme P, Denolle T, Dourmap C, Halimi JM, Girerd X, Rossignol P, Zannad F, Ormezzano O, Vaisse B, Herpin D, Ribstein J, Bouhanick B, Mourad JJ, Ferrari E, Chatellier G, Sapoval M, Azarine A, Azizi M; DENERHTN Investigators. Abdominal Aortic Calcifications Influences the Systemic and Renal Hemodynamic Response to Renal Denervation in the DENERHTN (Renal Denervation for Hypertension) Trial. J Am Heart Assoc. 2017;6(10). pii: e007062.
  33. Amato M, Veglia F, de Faire U, Giral P, Rauramaa R, Smit AJ, Kurl S, Ravani A, Frigerio B, Sansaro D, Bonomi A, Tedesco CC, Castelnuovo S, Mannarino E, Humphries SE, Hamsten A, Tremoli E, Baldassarre D; IMPROVE study group. Carotid plaque-thickness and common carotid IMT show additive value in cardiovascular risk prediction and reclassification. Atherosclerosis. 2017;263:412-419.
  34. Girerd X, Hanon O, Pannier B, Vaïsse B. [Development of a risk calculator for drug compliance in treated hypertensives: The FLAHS Compliance Calculator]. Ann Cardiol Angeiol (Paris). 2017;66(3):149-153.
  35. Gallo A, Rosenbaum D, Kanagasabapathy C, Girerd X. Effects of carotid baroreceptor stimulation on retinal arteriole remodeling evaluated with adaptive optics camera in resistant hypertensive patients. Ann Cardiol Angeiol (Paris). 2017;66(3):165-170.
  36. Frederiksen SD, Karlskov-Mortensen P, Pant SD, Guerin M, Lesnik P, Jørgensen CB, Cirera S, Bruun CS, Mark T, Fredholm M.Haplotypes on pig chromosome 3 distinguish metabolically healthy from unhealthy obese individuals. PLoS One. 2017;12(6):e0178828.
  37. Amsellem V, Abid S, Poupel L, Parpaleix A, Rodero M, Gary-Bobo G, Latiri M, Dubois-Rande JL, Lipskaia L, Combadiere C, Adnot S. Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension. Am J Respir Cell Mol Biol. 2017;56(5):597-608.
  38. Wargny M, Balkau B, Lange C, Charles MA, Giral P and Simon D. Association of fasting serum insulin and cancer mortality in a healthy population – 28-year follow-up of the French TELECOM Study. Diabetes Metab. 2017.
  39. Marcelin G, Ferreira A, Liu Y, Atlan M, Aron-Wisnewsky J, Pelloux V, Botbol Y, Ambrosini M, Fradet M, Rouault C, Henegar C, Hulot JS, Poitou C, Torcivia A, Nail-Barthelemy R, Bichet JC, Gautier EL and Clement K. A PDGFRalpha-Mediated Switch toward CD9high Adipocyte Progenitors Controls Obesity-Induced Adipose Tissue Fibrosis. Cell Metab. 2017;25:673-685.
  40. Manzoni G, Marinach C, Topcu S, Briquet S, Grand M, Tolle M, Gransagne M, Lescar J, Andolina C, Franetich JF, Zeisel MB, Huby T, Rubinstein E, Snounou G, Mazier D, Nosten F, Baumert TF and Silvie O. Plasmodium P36 determines host cell receptor usage during sporozoite invasion. Elife. 2017;6.
  41. Mahdessian H, Perisic Matic L, Lengquist M, Gertow K, Sennblad B, Baldassarre D, Veglia F, Humphries SE, Rauramaa R, de Faire U, Smit AJ, Giral P, Kurl S, Mannarino E, Tremoli E, Hamsten A, Eriksson P, Hedin U, Malarstig A and group Is. Integrative studies implicate matrix metalloproteinase-12 as a culprit gene for large-artery atherosclerotic stroke. J Intern Med. 2017.
  42. Kuburovic V, Vekic J, Zeljkovic A, Carrie A, Kotur-Stevuljevic J, Bojanin D, Kosutic J, Spasojevic-Kalimanovska V, Miljkovic M, Kuburovic N and Couvert P. The usefulness of advanced lipid and oxidative stress testing for diagnosis and management of low HDL-cholesterol phenotype: A case report. Clin Biochem. 2017.
  43. Gosse P, Cremer A, Pereira H, Bobrie G, Chatellier G, Chamontin B, Courand PY, Delsart P, Denolle T, Dourmap C, Ferrari E, Girerd X, Michel Halimi J, Herpin D, Lantelme P, Monge M, Mounier-Vehier C, Mourad JJ, Ormezzano O, Ribstein J, Rossignol P, Sapoval M, Vaisse B, Zannad F and Azizi M. Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension). Hypertension. 2017;69:494-500.
  44. Girerd X, Hanon O, Pannier B and Vaisse B. [Development of a risk calculator for drug compliance in treated hypertensives: The FLAHS Compliance Calculator]. Ann Cardiol Angeiol (Paris). 2017;66:149-153.
  45. Gallo A, Rosenbaum D, Kanagasabapathy C and Girerd X. Effects of carotid baroreceptor stimulation on retinal arteriole remodeling evaluated with adaptive optics camera in resistant hypertensive patients. Ann Cardiol Angeiol (Paris). 2017;66:165-170.
  46. Gallo A, Giral P, Carrie A, Carreau V, Beliard S, Bittar R, Maranghi M, Arca M, Cluzel P, Redheuil A, Bruckert E and Rosenbaum D. Early coronary calcifications are related to cholesterol burden in heterozygous familial hypercholesterolemia. J Clin Lipidol. 2017;11:704-711 e2.
  47. Frederiksen SD, Karlskov-Mortensen P, Pant SD, Guerin M, Lesnik P, Jorgensen CB, Cirera S, Bruun CS, Mark T and Fredholm M. Haplotypes on pig chromosome 3 distinguish metabolically healthy from unhealthy obese individuals. PloS one. 2017;12:e0178828.
  48. Folkersen L, Fauman E, Sabater-Lleal M, Strawbridge RJ, Franberg M, Sennblad B, Baldassarre D, Veglia F, Humphries SE, Rauramaa R, de Faire U, Smit AJ, Giral P, Kurl S, Mannarino E, Enroth S, Johansson A, Enroth SB, Gustafsson S, Lind L, Lindgren C, Morris AP, Giedraitis V, Silveira A, Franco-Cereceda A, Tremoli E, group Is, Gyllensten U, Ingelsson E, Brunak S, Eriksson P, Ziemek D, Hamsten A and Malarstig A. Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease. PLoS Genet. 2017;13:e1006706.
  49. Calippe B, Augustin S, Beguier F, Charles-Messance H, Poupel L, Conart JB, Hu SJ, Lavalette S, Fauvet A, Rayes J, Levy O, Raoul W, Fitting C, Denefle T, Pickering MC, Harris C, Jorieux S, Sullivan PM, Sahel JA, Karoyan P, Sapieha P, Guillonneau X, Gautier EL and Sennlaub F. Complement Factor H Inhibits CD47-Mediated Resolution of Inflammation. Immunity. 2017;46:261-272.
  50. Sharma A, Garg A, Elmariah S, Drachman D, Obiagwu C, Vallakati A, Sharma SK, Lavie CJ, Mukherjee D, Waksman R, Stefanini GG, Feres F, Marmur JD, Helft G. Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation in Diabetic and Non-Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Prog Cardiovasc Dis. 2018;60(4-5):500-507.
  51. Varenne O, Cook S, Sideris G, Kedev S, Cuisset T, Carrié D, Hovasse T, Garot P, El Mahmoud R, Spaulding C, Helft G, Diaz Fernandez JF, Brugaletta S, Pinar-Bermudez E, Mauri Ferre J, Commeau P, Teiger E, Bogaerts K, Sabate M, Morice MC, Sinnaeve PR; SENIOR investigators. Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial. Lancet. 2018;391(10115):41-50.
  52. Silvain J, Nguyen LS, Spagnoli V, Kerneis M, Guedeney P, Vignolles N, Cosker K, Barthelemy O, Le Feuvre C, Helft G, Collet JP, Montalescot G. Contrast-induced acute kidney injury and mortality in ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart. 2018;104(9):767-772.
  53. D’Ascenzo F, Iannaccone M, Saint-Hilary G, Bertaina M, Schulz-Schüpke S, Wahn Lee C, Chieffo A, Helft G, Gili S, Barbero U, Biondi Zoccai G, Moretti C, Ugo F, D’Amico M, Garbo R, Stone G, Rettegno S, Omedè P, Conrotto F, Templin C, Colombo A, Park SJ, Kastrati A, Hildick-Smith D, Gasparini M, Gaita F. Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients. Eur Heart J. 2017;38(42):3160-3172.
  54. Salem JE, Laveau F, Ceccaldi A, Funck-Brentano C, Hulot JS, Mameri A, Barthelemy O, Helft G, Feuvre CL, Isnard R, Hammoudi N. Impact of negative inotropic drugs on accuracy of diastolic stress echocardiography for evaluation of left ventricular filling pressure. Sci Rep. 2017;7(1):9537.
  55. Sharma A, Agrawal S, Garg A, Vallakati A, Lavie CJ, Helft G. Duration of dual antiplatelet therapy following drug-eluting stent implantation: A systemic review and meta-analysis of randomized controlled trials with longer follow up. Catheter Cardiovasc Interv. 2017;90(1):31-37.
  56. Palmerini T, Bacchi Reggiani L, Della Riva D, Romanello M, Feres F, Abizaid A, Gilard M, Morice MC, Valgimigli M, Hong MK, Kim BK, Jang Y, Kim HS, Park KW, Colombo A, Chieffo A, Ahn JM, Park SJ, Schüpke S, Kastrati A, Montalescot G, Steg PG, Diallo A, Vicaut E, Helft G, Biondi-Zoccai G, Xu B, Han Y, Genereux P, Bhatt DL, Stone GW. Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting. J Am Coll Cardiol. 2017;69(16):2011-2022.
  57. Verger EO, Armstrong P, Nielsen T, Chakaroun R, Aron-Wisnewsky J, Gøbel RJ, Schütz T, Delaere F, Gausseres N, Clément K, Holmes BA; MetaCardis Consortium Dietary Assessment in the MetaCardis Study: Development and Relative Validity of an Online Food Frequency Questionnaire. J Acad Nutr Diet. 2017;117(6):878-888.
  58. Buttgereit A, Lelios I, Yu X, Vrohlings M, Krakoski NR, Gautier EL, Nishinakamura R, Becher B and Greter M. Erratum: Sall1 is a transcriptional regulator defining microglia identity and function. Nat Immunol. 2017;18:246.
  59. Bittar R, Aslangul E, Giral P, Assoumou L, Valantin MA, Kalmykova O, Federspiel MC, Cherfils C, Costagliola D, Bonnefont-Rousselot D and group As. Lack of effects of statins on high-density lipoprotein subfractions in HIV-1-infected patients receiving protease inhibitors. C R Biol. 2017;340:109-113
  60. Amato M, Veglia F, de Faire U, Giral P, Rauramaa R, Smit AJ, Kurl S, Ravani A, Frigerio B, Sansaro D, Bonomi A, Tedesco CC, Castelnuovo S, Mannarino E, Humphries SE, Hamsten A, Tremoli E, Baldassarre D and group Is. Carotid plaque-thickness and common carotid IMT show additive value in cardiovascular risk prediction and reclassification. Atherosclerosis. 2017;263:412-419.
  61. Auvynet C, Baudesson de Chanville C, Hermand P, Dorgham K, Piesse C, Pouchy C, Carlier L, Poupel L, Barthélémy S, Felouzis V, Lacombe C, Sagan S, Salomon B, Deterre P, Sennlaub F, Combadière C. ECL1i, d(LGTFLKC), a novel, small peptide that specifically inhibits CCL2-dependent migration. FASEB J. 2016;30(6):2370-81.
  62. Llopis M, Cassard AM, Wrzosek L, Boschat L, Bruneau A, Ferrere G, Puchois V, Martin JC, Lepage P, Le Roy T, Lefèvre L, Langelier B, Cailleux F, González-Castro AM, Rabot S, Gaudin F, Agostini H, Prévot S, Berrebi D, Ciocan D, Jousse C, Naveau S, Gérard P, Perlemuter G. Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease. Gut. 2016;65(5):830-9
  63. Chousterman BG, Boissonnas A, Poupel L, Baudesson de Chanville C, Adam J, Tabibzadeh N, Licata F, Lukaszewicz AC, Lombès A, Deterre P, Payen D, Combadière C.Ly6Chigh Monocytes Protect against Kidney Damage during Sepsis via a CX3CR1-Dependent Adhesion Mechanism. J Am Soc Nephrol. 2016;27(3):792-803.
  64. Villeneuve F, Lim H and Girerd X. [Impact of the ExSel((R)) test administration on the excessive salt consumption in hypertensive patients followed in general practice]. Ann Cardiol Angeiol (Paris). 2016;65:142-5.
  65. Vancraeynest D, Roelants V, Bouzin C, Hanin FX, Walrand S, Bol V, Bol A, Pouleur AC, Pasquet A, Gerber B, Lesnik P, Huby T, Jamar F and Vanoverschelde JL. alphaVbeta3 integrin-targeted microSPECT/CT imaging of inflamed atherosclerotic plaques in mice. EJNMMI Res. 2016;6:29.
  66. Strawbridge RJ, Hilding A, Silveira A, Osterholm C, Sennblad B, McLeod O, Tsikrika P, Foroogh F, Tremoli E, Baldassarre D, Veglia F, Rauramaa R, Smit AJ, Giral P, Kurl S, Mannarino E, Grossi E, Syvanen AC, Humphries SE, de Faire U, Ostenson CG, Maegdefessel L, Hamsten A, Backlund A and Group IS. Soluble CD93 Is Involved in Metabolic Dysregulation but Does Not Influence Carotid Intima-Media Thickness. Diabetes. 2016;65:2888-99.
  67. Scicali R, Giral P, Gallo A, Di Pino A, Rabuazzo AM, Purrello F, Cluzel P, Redheuil A, Bruckert E and Rosenbaum D. HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients. Atherosclerosis. 2016;255:102-108.
  68. Sarrazy V, Viaud M, Westerterp M, Ivanov S, Giorgetti-Peraldi S, Guinamard R, Gautier EL, Thorp EB, De Vivo DC and Yvan-Charvet L. Disruption of Glut1 in Hematopoietic Stem Cells Prevents Myelopoiesis and Enhanced Glucose Flux in Atheromatous Plaques of ApoE(-/-) Mice. Circ Res. 2016;118:1062-77.
  69. Rosenbaum D, Mattina A, Koch E, Rossant F, Gallo A, Kachenoura N, Paques M, Redheuil A and Girerd X. Effects of age, blood pressure and antihypertensive treatments on retinal arterioles remodeling assessed by adaptive optics. J Hypertens. 2016;34:1115-22.
  70. Rosenbaum D, Kachenoura N, Koch E, Paques M, Cluzel P, Redheuil A and Girerd X. Relationships between retinal arteriole anatomy and aortic geometry and function and peripheral resistance in hypertensives. Hypertens Res. 2016;39:536-42.
  71. Pais R, Giral P, Khan JF, Rosenbaum D, Housset C, Poynard T, Ratziu V and Group LS. Fatty liver is an independent predictor of early carotid atherosclerosis. Journal of hepatology. 2016;65:95-102.
  72. Monneret D, Giral P, Bonnefont-Rousselot D and Roche F. Introducing High-Sensitivity Cardiac Troponin T as a Biomarker of OSA-Related Cardiovascular Morbidity in Obesity Hypoventilation Syndrome. Chest. 2016;150:1408-1409
  73. Helft G. New guidelines on duration of dual antiplatelet therapy in patients with coronary artery disease: what’s the novelty?J Thorac Dis. 2016;8(10):E1301-E1303.
  74. Sharma A, Helft G, Garg A, Agrawal S, Chatterjee S, Lavie CJ, Goel S, Mukherjee D, Marmur JD. Safety and efficacy of vorapaxar in secondary prevention of atherosclerotic disease: A meta-analysis of randomized control trials. Int J Cardiol. 2017;227:617-624.
  75. Hammoudi N, Laveau F, Helft G, Cozic N, Barthelemy O, Ceccaldi A, Petroni T, Berman E, Komajda M, Michel PL, Mallet A, Le Feuvre C, Isnard R. Low level exercise echocardiography helps diagnose early stage heart failure with preserved ejection fraction: a study of echocardiography versus catheterization. Clin Res Cardiol. 2017;106(3):192-201.
  76. Helft G. Dual antiplatelet therapy duration after drug-eluting stents: how long? J Thorac Dis. 2016;8(8):E844-6.
  77. Petroni T, Zaman A, Georges JL, Hammoudi N, Berman E, Segev A, Juliard JM, Barthelemy O, Silvain J, Choussat R, Le Feuvre C, Helft G. Primary percutaneous coronary intervention for ST elevation myocardial infarction in nonagenarians. Heart. 2016;102(20):1648-54.
  78. Helft G. The saga of the duration of dual antiplatelet therapy after drug-eluting stent placement. Arch Cardiovasc Dis. 2015;108(10):469-71.
  79. Sharma A, Lavie CJ, Helft G, Chatterjee S, Goel S, Garg A, Mukherjee D, Marmur JD. Role of Vorapaxar After Coronary Revascularization. Am J Cardiol. 2016;117(7):1059-64.
  80. Helft G, Steg PG, Le Feuvre C, Georges JL, Carrie D, Dreyfus X, Furber A, Leclercq F, Eltchaninoff H, Falquier JF, Henry P, Cattan S, Sebagh L, Michel PL, Tuambilangana A, Hammoudi N, Boccara F, Cayla G, Douard H, Diallo A, Berman E, Komajda M, Metzger JP, Vicaut E; OPTImal DUAL Antiplatelet Therapy Trial Investigators. Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: the OPTIDUAL randomized trial. Eur Heart J. 2016;37(4):365-74.
  81. Menezes S, Melandri D, Anselmi G, Perchet T, Loschko J, Dubrot J, Patel R, Gautier EL, Hugues S, Longhi MP, Henry JY, Quezada SA, Lauvau G, Lennon-Dumenil AM, Gutierrez-Martinez E, Bessis A, Gomez-Perdiguero E, Jacome-Galarza CE, Garner H, Geissmann F, Golub R, Nussenzweig MC and Guermonprez P. The Heterogeneity of Ly6Chi Monocytes Controls Their Differentiation into iNOS+ Macrophages or Monocyte-Derived Dendritic Cells. Immunity. 2016;45:1205-1218.
  82. Mancia G, Omboni S, Chazova I, Coca A, Girerd X, Haller H, Parati G, Pauletto P, Pupek-Musialik D, Svyshchenko Y and Group FS. Effects of the lercanidipine-enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database. J Hypertens. 2016;34:139-48.
  83. Lhermusier T, Severin S, Van Rothem J, Garcia C, Bertrand-Michel J, Le Faouder P, Hechler B, Broccardo C, Couvert P, Chimini G, Sie P and Payrastre B. ATP-binding cassette transporter 1 (ABCA1) deficiency decreases platelet reactivity and reduces thromboxane A2 production independently of hematopoietic ABCA1. J Thromb Haemost. 2016;14:585-95.
  84. Kim KW, Williams JW, Wang YT, Ivanov S, Gilfillan S, Colonna M, Virgin HW, Gautier EL and Randolph GJ. MHC II+ resident peritoneal and pleural macrophages rely on IRF4 for development from circulating monocytes. J Exp Med. 2016;213:1951-9.
  85. Ivanov S, Scallan JP, Kim KW, Werth K, Johnson MW, Saunders BT, Wang PL, Kuan EL, Straub AC, Ouhachi M, Weinstein EG, Williams JW, Briseno C, Colonna M, Isakson BE, Gautier EL, Forster R, Davis MJ, Zinselmeyer BH and Randolph GJ. CCR7 and IRF4-dependent dendritic cells regulate lymphatic collecting vessel permeability. J Clin Invest. 2016;126:1581-91.
  86. Hoang S, Girerd X and Giral P. Letter by Hoang et al Regarding Article, “Novel Biomarker of Oxidative Stress Is Associated With Risk of Death in Patients With Coronary Artery Disease”. Circulation. 2016;133:e666.
  87. Hekimian G, Kharcha F, Brechot N, Schmidt M, Ghander C, Lebreton G, Girerd X, Tresallet C, Trouillet JL, Leprince P, Chastre J, Combes A and Luyt CE. Extracorporeal membrane oxygenation for pheochromocytoma-induced cardiogenic shock. Ann Intensive Care. 2016;6:117.
  88. Girerd X, Hanon O, Pannier B, Mourad JJ and Vaisse B. [Determinants of controlled hypertension in patients treated with antihypertensive drugs in France: The French League Against Hypertension Survey (FLAHS 2015)]. Ann Cardiol Angeiol (Paris). 2016;65:219-22.
  89. Giral P, Hansel B and Chapman J. Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression After PCI: PRECISE-IVUS. J Am Coll Cardiol. 2016;67:234.
  90. Gallo A, Mattina A, Rosenbaum D, Koch E, Paques M and Girerd X. Retinal arteriolar remodeling evaluated with adaptive optics camera: Relationship with blood pressure levels. Ann Cardiol Angeiol (Paris). 2016;65:203-7.
  91. Gall J, Frisdal E, Bittar R, Le Goff W, Bruckert E, Lesnik P, Guerin M and Giral P. Association of Cholesterol Efflux Capacity With Clinical Features of Metabolic Syndrome: Relevance to Atherosclerosis. J Am Heart Assoc. 2016;5.
  92. El Khoury P, Waldmann E, Huby T, Gall J, Couvert P, Lacorte JM, Chapman J, Frisdal E, Lesnik P, Parhofer KG, Le Goff W and Guerin M. Extended-Release Niacin/Laropiprant Improves Overall Efficacy of Postprandial Reverse Cholesterol Transport. Arterioscler Thromb Vasc Biol. 2016;36:285-94.
  93. Douillard C, Houillier P, Nussberger J and Girerd X. SFE/SFHTA/AFCE Consensus on Primary Aldosteronism, part 2: First diagnostic steps. Ann Endocrinol (Paris). 2016;77:192-201.
  94. Douillard C, Houillier P, Nussberger J and Girerd X. Claire Douillard, Pascal Houillier, Juerg Nussberger and Xavier Girerd in response to the correspondence by Damien Denimal entitled: “Comments on French SFE/SFHTA/AFCE Consensus on Primary aldosteronism, Part 2: Diagnosis First steps”. Ann Endocrinol 2016. Ann Endocrinol (Paris). 2016;77:676.
  95. Denolle T, Chamontin B, Doll G, Fauvel JP, Girerd X, Herpin D, Vaisse B, Villeneuve F and Halimi JM. Management of resistant hypertension: expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology. J Hum Hypertens. 2016;30:657-663.
  96. Degos B, Nadjar Y, Amador Mdel M, Lamari F, Sedel F, Roze E, Couvert P and Mochel F. Natural history of cerebrotendinous xanthomatosis: a paediatric disease diagnosed in adulthood. Orphanet J Rare Dis. 2016;11:41.
  97. Buttgereit A, Lelios I, Yu X, Vrohlings M, Krakoski NR, Gautier EL, Nishinakamura R, Becher B and Greter M. Sall1 is a transcriptional regulator defining microglia identity and function. Nat Immunol. 2016;17:1397-1406.
  98. Azizi M, Pereira H, Hamdidouche I, Gosse P, et al and Investigators D. Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial. Circulation. 2016;134:847-57.
  99. Amar L, Baguet JP, Bardet S, Chaffanjon P, Chamontin B, Douillard C, Durieux P, Girerd X, Gosse P, Hernigou A, Herpin D, Houillier P, Jeunemaitre X, Joffre F, Kraimps JL, Lefebvre H, Menegaux F, Mounier-Vehier C, Nussberger J, Pagny JY, Pechere A, Plouin PF, Reznik Y, Steichen O, Tabarin A, Zennaro MC, Zinzindohoue F and Chabre O. SFE/SFHTA/AFCE primary aldosteronism consensus: Introduction and handbook. Ann Endocrinol (Paris). 2016;77:179-86.
  100. Arnold L, Perrin H, de Chanville CB, Saclier M, Hermand P, Poupel L, Guyon E, Licata F, Carpentier W, Vilar J, Mounier R, Chazaud B, Benhabiles N, Boissonnas A, Combadiere B, Combadiere C. CX3CR1 deficiency promotes muscle repair and regeneration by enhancing macrophage ApoE production. Nat Commun. 2015 Dec 3;6:8972.
  101. Rodero MP, Poupel L, Loyher PL, Hamon P, Licata F, Pessel C, Hume DA, Combadière C, Boissonnas A. Immune surveillance of the lung by migrating tissue monocytes. Elife. 2015 Jul 13;4:e07847.
  102. Tussiwand R and Gautier EL. Transcriptional Regulation of Mononuclear Phagocyte Development. Front Immunol. 2015;6:533.
  103. Szalat R, Monsel G, Le Goff W, Battistella M, Bengouffa D, Schlageter MH, Bouaziz JD, Arnulf B, Vignon M, Lesnik P, Saussine A, Malphettes M, Lazareth A, Vignon-Pennamen MD, Bagot M, Brouet JC, Fermand JP, Rybojad M and Asli B. The spectrum of neutrophilic dermatoses associated with monoclonal gammopathy: Association with IgA isotype and inflammatory profile. J Am Acad Dermatol. 2015;73:809-20.
  104. Silveira A, McLeod O, Strawbridge RJ, Gertow K, Sennblad B, Baldassarre D, Veglia F, Deleskog A, Persson J, Leander K, Gigante B, Kauhanen J, Rauramaa R, Smit AJ, Mannarino E, Giral P, Gustafsson S, Soderberg S, Ohrvik J, Humphries SE, Tremoli E, de Faire U and Hamsten A. Plasma IL-5 concentration and subclinical carotid atherosclerosis. Atherosclerosis. 2015;239:125-30.
  105. Sarrazy V, Sore S, Viaud M, Rignol G, Westerterp M, Ceppo F, Tanti JF, Guinamard R, Gautier EL and Yvan-Charvet L. Maintenance of Macrophage Redox Status by ChREBP Limits Inflammation and Apoptosis and Protects against Advanced Atherosclerotic Lesion Formation. Cell Rep. 2015;13:132-44.
  106. Loncar G, Barthelemy O, Berman E, Kerneis M, Petroni T, Payot L, Choussat R, Silvain J, Collet JP, Helft G, Montalescot G, Le Feuvre C. Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary intervention. Arch Cardiovasc Dis. 2015;108(11):554-62.
  107. Rosenbaum D, Girerd X, Kachenoura N, De Cesare A, Cluzel P and Redheuil A. 7c.08: Stiffness Modifications Along Aortic Arch Are Different in Hypertensives and Controls. J Hypertens. 2015;33 Suppl 1:e98.
  108. Repetto E, Lichtenstein L, Hizir Z, Tekaya N, Benahmed M, Ruidavets JB, Zaragosi LE, Perret B, Bouchareychas L, Genoux A, Lotte R, Ruimy R, Ferrieres J, Barbry P, Martinez LO and Trabucchi M. RNY-derived small RNAs as a signature of coronary artery disease. BMC Med. 2015;13:259.
  109. Rached F, Lhomme M, Camont L, Gomes F, Dauteuille C, Robillard P, Santos RD, Lesnik P, Serrano CV, Jr., Chapman MJ and Kontush A. Defective functionality of small, dense HDL3 subpopulations in ST segment elevation myocardial infarction: Relevance of enrichment in lysophosphatidylcholine, phosphatidic acid and serum amyloid A. Biochim Biophys Acta. 2015;1851:1254-61.
  110. Potiron A, Gerard P, Le Roy T, Lesnik P, Maguin E and Rhimi M. Recent Patents on Hypocholesterolemic Therapeutic Strategies: An Update. Recent Adv DNA Gene Seq. 2015;9:36-44.
  111. Picard HL, Thurairajasingam N, Decramer S, Girerd X, Oshaugnessy K, Mulatero P, Roussey G, Tack I, Unwin R, Vargas-Poussou R and Jeunemaitre X. 1a.01: Mutations Affecting the Conserved Acidic Motif of Wnk1 Cause Inherited Normotensive Hyperkalemic Acidosis. J Hypertens. 2015;33 Suppl 1:e1.
  112. Persson J, Strawbridge RJ, McLeod O, Gertow K, Silveira A, Baldassarre D, Van Zuydam N, Shah S, Fava C, Gustafsson S, Veglia F, Sennblad B, Larsson M, Sabater-Lleal M, Leander K, Gigante B, Tabak A, Kivimaki M, Kauhanen J, Rauramaa R, Smit AJ, Mannarino E, Giral P, Humphries SE, Tremoli E, de Faire U, Lind L, Ingelsson E, Hedblad B, Melander O, Kumari M, Hingorani A, Morris AD, Palmer CN, Lundman P, Ohrvik J, Soderberg S, Hamsten A and Group IS. Sex-Specific Effects of Adiponectin on Carotid Intima-Media Thickness and Incident Cardiovascular Disease. J Am Heart Assoc. 2015;4:e001853.
  113. Pant SD, Karlskov-Mortensen P, Jacobsen MJ, Cirera S, Kogelman LJ, Bruun CS, Mark T, Jorgensen CB, Grarup N, Appel EV, Galjatovic EA, Hansen T, Pedersen O, Guerin M, Huby T, Lesnik P, Meuwissen TH, Kadarmideen HN and Fredholm M. Comparative Analyses of QTLs Influencing Obesity and Metabolic Phenotypes in Pigs and Humans. PloS one. 2015;10:e0137356.
  114. Paillard F, Bruckert E, Naelten G, Picard P and van Ganse E. Cardiovascular risk and lifestyle habits of consumers of a phytosterol-enriched yogurt in a real-life setting. J Hum Nutr Diet. 2015;28:226-35.
  115. Merono T, Brites F, Dauteuille C, Lhomme M, Menafra M, Arteaga A, Castro M, Saez MS, Ballerga EG, Sorroche P, Rey J, Lesnik P, Sorda JA, Chapman MJ, Kontush A and Daruich J. Metabolic alterations, HFE gene mutations and atherogenic lipoprotein modifications in patients with primary iron overload. Clinical science. 2015;128:609-18.
  116. Meikle PJ, Wong G, Tan R, Giral P, Robillard P, Orsoni A, Hounslow N, Magliano DJ, Shaw JE, Curran JE, Blangero J, Kingwell BA and Chapman MJ. Statin action favors normalization of the plasma lipidome in the atherogenic mixed dyslipidemia of MetS: potential relevance to statin-associated dysglycemia. Journal of lipid research. 2015;56:2381-92.
  117. Mavromati M, Amsallem M, Jublanc C, Bruckert E, Leenhardt L and Girerd X. Questioning the pathogenic role of the pTyr791Phe mutation of the RET proto-oncogene: Insight from a case report. Ann Endocrinol (Paris). 2015;76:690-4.
  118. Mattina A, Rosenbaum D, Kanagasabapathy C, Koch E, Paques M and Girerd X. 7d.02: Effect of a Short-Term Antihypertensive Treatment on Retinal Arterioles Evaluated with Adaptive Optics Retinal Camera. J Hypertens. 2015;33 Suppl 1:e100.
  119. Helft G, Georges JL, Mouranche X, Loyeau A, Spaulding C, Caussin C, Benamer H, Garot P, Livarek B, Teiger E, Varenne O, Monségu J, Mapouata M, Petroni T, Hammoudi N, Lambert Y, Dupas F, Laborne F, Lapostolle F, Lefort H, Juliard JM, Letarnec JY, Lamhaut L, Lebail G, Boche T, Jouven X, Bataille S; e-MUST and CARDIO-ARSIF Registries. Outcomes of primary percutaneous coronary interventions in nonagenarians with acute myocardial infarction. Int J Cardiol. 2015 Aug 1;192:24-9.
  120. Barthélémy O, Degrell P, Berman E, Kerneis M, Petroni T, Silvain J, Payot L, Choussat R, Collet JP, Helft G, Montalescot G, Le Feuvre C. Sex-related differences after contemporary primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Arch Cardiovasc Dis. 2015;108(8-9):428-36.
  121. Helft G. Prolonged dual antiplatelet therapy after drug-eluting stent reduces the risk of stent thrombosis and major cardiovascular events but increases the rate of bleeding. Evid Based Med. 2015;20(3):99.
  122. Montalescot G, Helft G. The arranged marriage of cangrelor and bivalirudin. JACC Cardiovasc Interv. 2015 Mar;8(3):434-435.
  123. Petroni T, Zaman A, Georges JL, Hammoudi N, Berman E, Segev A, Juliard JM, Barthelemy O, Silvain J, Choussat R, Le Feuvre C, Helft G. Primary percutaneous coronary intervention for ST elevation myocardial infarction in nonagenarians: a multicenter study. J Am Geriatr Soc. 2015;63(2):384-6.
  124. Girerd X, Villeneuve F, Gury C, Giral P and Rosenbaum D. 5d.01: Decrease in Excess Salt Consumption for Hypertensive Subjects Living in the Paris Area. J Hypertens. 2015;33 Suppl 1:e71.
  125. Girerd X, Villeneuve F, Deleste F, Giral P and Rosenbaum D. [Development and evaluation of ExSel Test to screen for excess salt intake in hypertensive subjects]. Ann Cardiol Angeiol (Paris). 2015;64:124-7.
  126. Girerd X, Hanon O, Pannier B, Mourad JJ and Vaisse B. [Hypertension in the elderly in France: Characteristics of treatments and frequency of cognitive complaint according to the 2014 French League against Hypertension Survey]. Ann Cardiol Angeiol (Paris). 2015;64:145-9.
  127. Frisdal E, Le Lay S, Hooton H, Poupel L, Olivier M, Alili R, Plengpanich W, Villard EF, Gilibert S, Lhomme M, Superville A, Miftah-Alkhair L, Chapman MJ, Dallinga-Thie GM, Venteclef N, Poitou C, Tordjman J, Lesnik P, Kontush A, Huby T, Dugail I, Clement K, Guerin M and Le Goff W. Adipocyte ATP-binding cassette G1 promotes triglyceride storage, fat mass growth, and human obesity. Diabetes. 2015;64:840-55.
  128. Bouchareychas L, Pirault J, Saint-Charles F, Deswaerte V, Le Roy T, Jessup W, Giral P, Le Goff W, Huby T, Gautier EL and Lesnik P. Promoting macrophage survival delays progression of pre-existing atherosclerotic lesions through macrophage-derived apoE. Cardiovasc Res. 2015;108:111-23.
  129. Anjani K, Lhomme M, Sokolovska N, Poitou C, Aron-Wisnewsky J, Bouillot JL, Lesnik P, Bedossa P, Kontush A, Clement K, Dugail I and Tordjman J. Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity. Journal of hepatology. 2015;62:905-12.
  130. Rodero MP, Licata F, Poupel L, Hamon P, Khosrotehrani K, Combadiere C, Boissonnas A. In vivo imaging reveals a pioneer wave of monocyte recruitment into mouse skin wounds. PLoS One. 2014;9(10):e108212.
  131. CCR5 as a treatment target in pulmonary arterial hypertension. Amsellem V, Lipskaia L, Abid S, Poupel L, Houssaini A, Quarck R, Marcos E, Mouraret N, Parpaleix A, Bobe R, Gary-Bobo G, Saker M, Dubois-Randé JL, Gladwin MT, Norris KA, Delcroix M, Combadière C, Adnot S. Circulation. 2014;130(11):880-891.
  132. Lécuyer E, Rakotobe S, Lengliné-Garnier H, Lebreton C, Picard M, Juste C, Fritzen R, Eberl G, McCoy KD, Macpherson AJ, Reynaud CA, Cerf-Bensussan N, Gaboriau-Routhiau V. Segmented filamentous bacterium uses secondary and tertiary lymphoid tissues to induce gut IgA and specific T helper 17 cell responses . Immunity. 2014 Apr 17;40(4):608-20.
  133. Szalat R, Pirault J, Fermand JP, Carrie A, Saint-Charles F, Olivier M, Robillard P, Frisdal E, Villard EF, Cathebras P, Bruckert E, Chapman MJ, Giral P, Guerin M, Lesnik P and Le Goff W. Physiopathology of necrobiotic xanthogranuloma with monoclonal gammopathy. J Intern Med. 2014;276:269-84.
  134. Strawbridge RJ, Deleskog A, McLeod O, Folkersen L, Kavousi M, Gertow K, Baldassarre D, Veglia F, Leander K, Gigante B, Kauhanen J, Rauramaa R, Smit AJ, Mannarino E, Giral P, Dehghan A, Hofman A, Franco OH, Humphries SE, Tremoli E, de Faire U, Gustafsson S, Ostensson CG, Eriksson P, Ohrvik J and Hamsten A. A serum 25-hydroxyvitamin D concentration-associated genetic variant in DHCR7 interacts with type 2 diabetes status to influence subclinical atherosclerosis (measured by carotid intima-media thickness). Diabetologia. 2014;57:1159-72.
  135. Perazzo H, Munteanu M, Ngo Y, Lebray P, Seurat N, Rutka F, Couteau M, Jacqueminet S, Giral P, Monneret D, Imbert-Bismut F, Ratziu V, Hartemann-Huertier A, Housset C, Poynard T and Consortium F. Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia. Aliment Pharmacol Ther. 2014;40:1081-93.
  136. Nascimento M, Huang SC, Smith A, Everts B, Lam W, Bassity E, Gautier EL, Randolph GJ and Pearce EJ. Ly6Chi monocyte recruitment is responsible for Th2 associated host-protective macrophage accumulation in liver inflammation due to schistosomiasis. PLoS Pathog. 2014;10:e1004282.
  137. McLeod O, Silveira A, Fredrikson GN, Gertow K, Baldassarre D, Veglia F, Sennblad B, Strawbridge RJ, Larsson M, Leander K, Gigante B, Kauhanen J, Rauramaa R, Smit AJ, Mannarino E, Giral P, Humphries SE, Tremoli E, de Faire U, Ohrvik J, Nilsson J and Hamsten A. Plasma autoantibodies against apolipoprotein B-100 peptide 210 in subclinical atherosclerosis. Atherosclerosis. 2014;232:242-8.
  138. Mancia G, Coca A, Chazova I, Girerd X, Haller H, Pauletto P, Pupek-Musialik D, Svyshchenko Y and investigators F. Effects on office and home blood pressure of the lercanidipine-enalapril combination in patients with Stage 2 hypertension: a European randomized, controlled clinical trial. J Hypertens. 2014;32:1700-7.
  139. Koch E, Rosenbaum D, Brolly A, Sahel JA, Chaumet-Riffaud P, Girerd X, Rossant F and Paques M. Morphometric analysis of small arteries in the human retina using adaptive optics imaging: relationship with blood pressure and focal vascular changes. J Hypertens. 2014;32:890-8.
  140. Gomez Rosso L, Lhomme M, Merono T, Sorroche P, Catoggio L, Soriano E, Saucedo C, Malah V, Dauteuille C, Boero L, Lesnik P, Robillard P, John Chapman M, Brites F and Kontush A. Altered lipidome and antioxidative activity of small, dense HDL in normolipidemic rheumatoid arthritis: relevance of inflammation. Atherosclerosis. 2014;237:652-60.
  141. Giral P, Simon D and Chapman MJ. Letter by Giral et al regarding article, “lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER trial (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin)”. Circulation. 2014;130:e151.
  142. Gilibert S, Galle-Treger L, Moreau M, Saint-Charles F, Costa S, Ballaire R, Couvert P, Carrie A, Lesnik P and Huby T. Adrenocortical scavenger receptor class B type I deficiency exacerbates endotoxic shock and precipitates sepsis-induced mortality in mice. Journal of immunology. 2014;193:817-26.
  143. Gigante B, Leander K, Vikstrom M, Baldassarre D, Veglia F, Strawbridge RJ, McLeod O, Gertow K, Sennblad B, Shah S, Zabaneh D, Humphries SE, Kauhanen J, Rauramaa R, Smit AJ, Mannarino E, Giral P, Tremoli E, Hamsten A, Frostegard J, de Faire U and Group IS. Low levels of IgM antibodies against phosphorylcholine are associated with fast carotid intima media thickness progression and cardiovascular risk in men. Atherosclerosis. 2014;236:394-9.
  144. Gautier EL and Yvan-Charvet L. Understanding macrophage diversity at the ontogenic and transcriptomic levels. Immunol Rev. 2014;262:85-95.
  145. Gautier EL, Ivanov S, Williams JW, Huang SC, Marcelin G, Fairfax K, Wang PL, Francis JS, Leone P, Wilson DB, Artyomov MN, Pearce EJ and Randolph GJ. Gata6 regulates aspartoacylase expression in resident peritoneal macrophages and controls their survival. J Exp Med. 2014;211:1525-31.
  146. Epelman S, Lavine KJ, Beaudin AE, Sojka DK, Carrero JA, Calderon B, Brija T, Gautier EL, Ivanov S, Satpathy AT, Schilling JD, Schwendener R, Sergin I, Razani B, Forsberg EC, Yokoyama WM, Unanue ER, Colonna M, Randolph GJ and Mann DL. Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity. 2014;40:91-104.
  147. Desbois AC, Wechsler B, Cluzel P, Helft G, Boutin D, Piette JC, Cacoub P, Saadoun D. [Cardiovascular involvement in Behçet’s disease]. Rev Med Interne. 2014;35(2):103-11. Review.
  148. Denolle T, Chamontin B, Doll G, Fauvel JP, Girerd X, Herpin D, Vaisse B, Villeneuve F and Halimi JM. [Management of resistant hypertension. Expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology]. Presse Med. 2014;43:1325-31.
  149. Chapman MJ, Orsoni A, Robillard P, Hounslow N, Sponseller CA and Giral P. Effect of high-dose pitavastatin on glucose homeostasis in patients at elevated risk of new-onset diabetes: insights from the CAPITAIN and PREVAIL-US studies. Curr Med Res Opin. 2014;30:775-84.
  150. Blacher J, Halimi JM, Hanon O, Mourad JJ, Pathak A, Schnebert B, Girerd X and French Society of H. Management of hypertension in adults: the 2013 French Society of Hypertension guidelines. Fundam Clin Pharmacol. 2014;28:1-9.
  151. Beliard S, Carreau V, Carrie A, Giral P, Duchene E, Farnier M, Ferrieres J, Fredenrich A, Krempf M, Luc G, Moulin P and Bruckert E. Improvement in LDL-cholesterol levels of patients with familial hypercholesterolemia: can we do better? Analysis of results obtained during the past two decades in 1669 French subjects. Atherosclerosis. 2014;234:136-41.
    aa